BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34981667)

  • 1. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.
    Wu D; Yang Y; Hou Y; Zhao Z; Liang N; Yuan P; Yang T; Xing J; Li J
    Cancer Commun (Lond); 2022 Jan; 42(1):37-55. PubMed ID: 34981667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
    Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
    Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
    Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
    Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
    Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
    Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
    Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
    Ma APY; Yeung CLS; Tey SK; Mao X; Wong SWK; Ng TH; Ko FCF; Kwong EML; Tang AHN; Ng IO; Cai SH; Yun JP; Yam JWP
    Cancer Res; 2021 Jul; 81(13):3679-3692. PubMed ID: 33975883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation.
    Li Y; Kasim V; Yan X; Li L; Meliala ITS; Huang C; Li Z; Lei K; Song G; Zheng X; Wu S
    Theranostics; 2019; 9(25):7599-7615. PubMed ID: 31695789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet.
    Alberdi G; Rodríguez VM; Macarulla MT; Miranda J; Churruca I; Portillo MP
    Nutrition; 2013 Mar; 29(3):562-7. PubMed ID: 23274094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of SIRT1 by L-serine increases fatty acid oxidation and reverses insulin resistance in C2C12 myotubes.
    Sim WC; Kim DG; Lee W; Sim H; Choi YJ; Lee BH
    Cell Biol Toxicol; 2019 Oct; 35(5):457-470. PubMed ID: 30721374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Kohjima M; Enjoji M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Takayanagi R; Nakamuta M
    Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptations of hepatic lipid metabolism and mitochondria in dairy cows with mild fatty liver.
    Du X; Shen T; Wang H; Qin X; Xing D; Ye Q; Shi Z; Fang Z; Zhu Y; Yang Y; Peng Z; Zhao C; Lv B; Li X; Liu G; Li X
    J Dairy Sci; 2018 Oct; 101(10):9544-9558. PubMed ID: 30100495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
    Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
    Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin 1 is involved in oleic acid-induced calf hepatocyte steatosis via alterations in lipid metabolism-related proteins.
    Ding H; Li Y; Liu L; Hao N; Zou S; Jiang Q; Liang Y; Ma N; Feng S; Wang X; Wu J; Loor JJ
    J Anim Sci; 2021 Oct; 99(10):. PubMed ID: 34436591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of divergence in residual feed intake on expression of lipid metabolism-related genes in the liver of meat-type ducks1.
    Jin S; Yang L; Fan X; Wu M; Xu Y; Chen X; Lin Z; Geng Z
    J Anim Sci; 2019 Sep; 97(9):3947-3957. PubMed ID: 31325379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming.
    Zhang Z; Li TE; Chen M; Xu D; Zhu Y; Hu BY; Lin ZF; Pan JJ; Wang X; Wu C; Zheng Y; Lu L; Jia HL; Gao S; Dong QZ; Qin LX
    Br J Cancer; 2020 Jan; 122(2):209-220. PubMed ID: 31819189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of black seed (Nigella sativa) extract on lipid metabolism in HepG2 cells.
    Haas MJ; Naem E; Almdallaleh S; Mooradian AD
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Aug; 1867(8):159155. PubMed ID: 35483558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid synthesis is critical for stem cell pluripotency via promoting mitochondrial fission.
    Wang L; Zhang T; Wang L; Cai Y; Zhong X; He X; Hu L; Tian S; Wu M; Hui L; Zhang H; Gao P
    EMBO J; 2017 May; 36(10):1330-1347. PubMed ID: 28377463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
    J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.